Want to see LYRA full AI Analyst Report?
Lyra Therapeutics (LYRA) Income Statement
Lyra Therapeutics Income Statement
Last quarter (Q4 2025), Lyra Therapeutics's total revenue was $7.00K, a decrease of 96.65% from the same quarter last year. In Q4, Lyra Therapeutics's net income was $-6.95M. See Lyra Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 398.00K | $ 1.53M | $ 1.56M | $ 1.36M | $ 285.00K | |
| $ 398.00K | $ 1.53M | $ 1.56M | $ 1.36M | $ -29.41M | |
| $ 29.95M | $ 97.88M | $ 68.68M | $ 57.67M | $ 14.21M | |
| Depreciation and Amortization | $ 459.00K | $ 471.00K | $ 278.00K | $ 1.07M | $ 1.00M |
| $ -29.09M | $ -60.26M | $ -65.25M | $ -53.92M | $ -42.61M | |
| $ -31.02M | $ -96.35M | $ -67.12M | $ -56.31M | $ -43.62M | |
| $ 2.11M | $ 2.95M | $ 4.50M | $ 1.04M | $ 102.00K | |
| $ -28.91M | $ -93.40M | $ -62.62M | $ -55.27M | $ -43.51M | |
| $ -28.92M | $ -93.44M | $ -62.68M | $ -55.28M | $ -43.51M | |
| Per Share Metrics | |||||
| Basic EPS | $ -18.62 | $ -1.43 | $ -1.26 | $ -1.83 | $ -3.35 |
| Diluted EPS | $ -18.62 | $ -1.43 | $ -1.26 | $ -1.83 | $ -3.35 |
| Weighted Average Shares Outstanding | 15.53M | 65.11M | 49.75M | 30.24M | 12.99M |
| Weighted Average Shares Outstanding (Diluted) | 15.53M | 65.11M | 49.80M | 30.24M | 12.99M |
Currency in USD
